Pharmaceutical News and Articles

Women's Fracture Rates, Risk Vary by Race, Ethnicity

Racial and ethnic differences exist in fracture rates and risk among women, according to a study published online Aug. 15 in the Journal of Bone and Mineral Res

Study Quantifies COVID-19-Linked Deficit in Arthroplasties in the U.K.

The COVID-19-induced deficit in arthroplasty procedures is equivalent to 71.6 percent of a year of normal expected operating activity, according to a study publ

Iron Deficiency Common, Often Persistent

Iron deficiency (ID) is common in an American statewide health system, and the time to resolution is prolonged, according to a study published online Aug. 15 in

1 in 4 Brain Injured Patients Who Seem Unresponsive Have 'Covert' Consciousness

such as how can we harness that unseen cognitive capacity to establish a system of communication and promote further recovery Bodien said in a hospital news rel

Brain-Computer Combo Lets Mute Man With ALS 'Talk' Again

and then the words they re trying to say. One of the roadblocks for developing these sort of brain-computer interfaces (BCIs) is that it takes time for the comp

WHO Declares Africa Mpox Outbreak a Global Health Emergency

The World Health Organization on Wednesday made the rare move of declaring an ongoing African outbreak of mpox a global health emergency.A new clade (strain) of

Frequent Coffee Drinkers Could Put Their Hearts at Risk

had significantly elevated heart rate and blood pressure even after five minutes of rest following a three-minute step test. Due to its effect on the autonomic

New Deals Will Cut Medicare Costs for Expensive Drugs

The Biden administration said Thursday that it has signed deals with drug companies that will lower the prices on 10 of the most popular and expensive drugs use

CDC Warns of Resurgence of Parvovirus B19

In a health alert issued by the U.S. Centers for Disease Control and Prevention, the agency said it has received reports of higher test positivity rates for par

FDA Approves Niktimvo (axatilimab-csfr) for the Treatment of Chronic Graft-Versus-Host Disease (GVHD)